Evidence map›Paper›PMID 25774501›Full record

ArticleThe Journal of clinical investigation2015

Progesterone and HMOX-1 promote fetal growth by CD8+ T cell modulation.

María Emilia Solano, Mirka Katharina Kowal, Greta Eugenia O'Rourke, Andrea Kristina Horst, Kathrin Modest, Torsten Plösch, Roja Barikbin, Chressen Catharina Remus, Robert G Berger, Caitlin Jago and 8 more

Open access · bronzeAbstract read
In one paragraph

Article in The Journal of clinical investigation, 2015. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 35 papers.

0numbers the graph read from it
0cells of the map it votes in
35citing papers in PubMed
7.1field-weighted citation impact, top 3% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

35 citing papers in PubMed, 84 citations in OpenAlex.

  1. Trial
  2. Article
  3. Effects of the gut microbiota on placental angiogenesis and intrauterine growth in gnotobiotic mice.Proceedings of the National Academy of Sciences of the United States of America · 2025
    Article
  4. Pregnancy-acquired memory CD4Nature communications · 2025
    Article
  5. Article
  6. Review
  7. Review
  8. Article
  9. Article
  10. Review
  11. Review
  12. Article
  13. Review
  14. Observational
  15. Review
  16. Disruption of Glucocorticoid Action on CD11cFrontiers in immunology · 2021
    Article
  17. Article
  18. Review
  19. Review
  20. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

18 authors at 7 institutions in 5 countries.

María Emilia Solano
Mirka Katharina Kowal
Greta Eugenia O'Rourke
Andrea Kristina Horst
Kathrin Modest
Torsten Plösch
Roja Barikbin
Chressen Catharina Remus
Robert G Berger
Caitlin Jago
Hoang Ho
Gabriele Sass
Victoria J Parker
John P Lydon
Francesco J DeMayo
Kurt Hecher
Khalil Karimi
Petra Clara Arck
University Medical Center Hamburg-Eppendorf · DEBaylor College of Medicine · USUniversität Hamburg · DEIntrinsik (Canada) · CAMcMaster University · CAUniversity of Edinburgh · GBUniversity of Groningen · NL

Funding

Environmental Signaling in Reproduction and PregnancyZIAES103311 · NIEHS · NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES · PI DEMAYO, FRANCESCO · 2016 to 2025
$30.5M
6 · The paper itself

Abstract

Intrauterine growth restriction (IUGR) affects up to 10% of pregnancies in Western societies. IUGR is a strong predictor of reduced short-term neonatal survival and impairs long-term health in children. Placental insufficiency is often associated with IUGR; however, the molecular mechanisms involved in the pathogenesis of placental insufficiency and IUGR are largely unknown. Here, we developed a mouse model of fetal-growth restriction and placental insufficiency that is induced by a midgestational stress challenge. Compared with control animals, pregnant dams subjected to gestational stress exhibited reduced progesterone levels and placental heme oxygenase 1 (Hmox1) expression and increased methylation at distinct regions of the placental Hmox1 promoter. These stress-triggered changes were accompanied by an altered CD8+ T cell response, as evidenced by a reduction of tolerogenic CD8+CD122+ T cells and an increase of cytotoxic CD8+ T cells. Using progesterone receptor- or Hmox1-deficient mice, we identified progesterone as an upstream modulator of placental Hmox1 expression. Supplementation of progesterone or depletion of CD8+ T cells revealed that progesterone suppresses CD8+ T cell cytotoxicity, whereas the generation of CD8+CD122+ T cells is supported by Hmox1 and ameliorates fetal-growth restriction in Hmox1 deficiency. These observations in mice could promote the identification of pregnancies at risk for IUGR and the generation of clinical interventional strategies.

Indexed as

AnimalsCD8-Positive T-LymphocytesDisease Models, AnimalDNA MethylationDrug Evaluation, PreclinicalFemaleFetal DevelopmentFetal Growth RetardationFetusHeme Oxygenase-1MaleMembrane ProteinsMiceMice, Inbred BALB CMice, Inbred C57BLMice, Inbred DBAHeme Oxygenase-1Hmox1 protein, mouseMembrane ProteinsProgesteroneRNA, Messenger

Identifiers

PMID25774501
PMCPMC4396482
OpenAlexW2072828642

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.